Abstract
Carbamylated darbepoetin is a promising pharmacological agent with universal cytoprotective activity. To assess the acute toxicity, the drug was administered to white laboratory mice and white laboratory rats subcutaneously (from 1000 to 5000 μg / kg) and intravenously (500 to 2500 μg / kg). There was no lethality and no phenotypic changes (including from the red blood sprout) in both species of animals. The study showed that the drug carbamylated darbepoetin (Pharmapark, Russia) belongs to the IV class of low-toxic drugs.
Full text article
Generated from XML file
Authors
Pavel D Kolesnichenko, Oleg S Gudyrev, Maksim A Zhuchenko, Nina I Zhernakova, Alexandr V Faitelson, Marina A Pershina, & Vladislav O Soldatov. (2018). Evaluation of carbamylated darbepoetin acute toxicity. International Journal of Research in Pharmaceutical Sciences, 9(3), 620–625. Retrieved from https://ijrps.com/home/article/view/4298
Copyright (c) 2018 International Journal of Research in Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.